XML 40 R55.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary Financial Information (Consolidated Statements of Cash Flows ) (Details) (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Operating activities:    
Net cash (used for) provided by operating activities $ 1,709 $ 7,574
INVESTING ACTIVITIES:    
Proceeds from sale of marketable securities 3,724 3,101
Purchases of marketable securities (2,597) (1,936)
Capital expenditures (8,033) (4,080)
Proceeds from sale of assets 0 1,482
Purchase of business (5,847) 0
Intercompany transactions 0  
Net cash used for investing activities (12,753) (1,433)
FINANCING ACTIVITIES:    
Net payments under lines-of-credit 0 (51)
Proceeds from exercise of stock options 838 219
Repayment of debt (295) (393)
Change in ESOP guarantee 206 213
Other   (180)
Net cash provided by (used for) financing activities 749 (12)
Effect of exchange rate changes on cash 454 (675)
Net change in cash and cash equivalents (9,841) 5,454
Cash and cash equivalents at beginning of period 121,660 89,473
Cash and cash equivalents at end of period 111,819 94,927
Parent
   
Operating activities:    
Net cash (used for) provided by operating activities 10,999 6,557
INVESTING ACTIVITIES:    
Proceeds from sale of marketable securities   0
Purchases of marketable securities   0
Capital expenditures (1,318) (3,354)
Proceeds from sale of assets   0
Intercompany transactions (13,303)  
Net cash used for investing activities (14,621) (3,354)
FINANCING ACTIVITIES:    
Proceeds from exercise of stock options 838 219
Change in ESOP guarantee 206  
Other   213
Net cash provided by (used for) financing activities 1,044 432
Net change in cash and cash equivalents (2,578) 3,635
Cash and cash equivalents at beginning of period 79,412 55,958
Cash and cash equivalents at end of period 76,834 59,593
Guarantors
   
Operating activities:    
Net cash (used for) provided by operating activities 1,267 (1,276)
INVESTING ACTIVITIES:    
Proceeds from sale of marketable securities   0
Purchases of marketable securities   0
Capital expenditures (1,116) (211)
Proceeds from sale of assets   1,482
Net cash used for investing activities (1,116) 1,271
FINANCING ACTIVITIES:    
Repayment of debt (151)  
Net cash provided by (used for) financing activities (151)  
Net change in cash and cash equivalents   (5)
Cash and cash equivalents at beginning of period 0 5
Cash and cash equivalents at end of period 0 0
Non Guarantors
   
Operating activities:    
Net cash (used for) provided by operating activities (10,557) 2,293
INVESTING ACTIVITIES:    
Proceeds from sale of marketable securities 3,724 3,101
Purchases of marketable securities (2,597) (1,936)
Capital expenditures (5,599) (515)
Proceeds from sale of assets   0
Purchase of business (5,847)  
Intercompany transactions 13,303  
Net cash used for investing activities 2,984 650
FINANCING ACTIVITIES:    
Net payments under lines-of-credit   (51)
Proceeds from exercise of stock options   0
Repayment of debt (144)  
Other   (393)
Net cash provided by (used for) financing activities (144) (444)
Effect of exchange rate changes on cash 454 (675)
Net change in cash and cash equivalents (7,263) 1,824
Cash and cash equivalents at beginning of period 42,248 33,510
Cash and cash equivalents at end of period 34,985 35,334
Eliminations
   
INVESTING ACTIVITIES:    
Purchase of business 0  
FINANCING ACTIVITIES:    
Proceeds from exercise of stock options $ 0